Cassava Sciences | PTIE - Current Liabilities

Stock Price
2.16
Daily Change
0.03 1.41%
Monthly
6.40%
Yearly
-13.60%
Q1 Forecast
2.06

Cassava Sciences reported $48.05M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 16.5B 1.91B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Biogen USD 3.35B 59.4M Dec/2025
Cara Therapeutics USD 10.68M 9.48M Jun/2025
Cassava Sciences USD 48.05M 716K Sep/2025
Eisai JPY 387.67B 9.42B Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Geron USD 87.71M 23.43M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 32B 286M Sep/2025
Novavax USD 429.87M 40.73M Sep/2025
Pfizer USD 36.6B 1.13B Sep/2025
Roche Holding CHF 28B 421M Dec/2025